Silverberg Bernstein Capital Management’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
Other funds holding NEO
PCM
MWM
MNBTD
LSERS
SOADOR
PFSRSONJ
YCM
Silverberg Bernstein Capital Management's NEO Position: Q2 2026 in Review
Silverberg Bernstein Capital Management reduced its NeoGenomics (NEO) stake by 4.2% in Q2 2026, selling an estimated $16.4K and leaving 38,980 shares worth $569K. The position accounts for 0.22% of the portfolio, ranked #45.
Silverberg Bernstein Capital Management first reported a position in NEO in Q4 2023 and has held it in 11 quarters since. 54 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- Silverberg Bernstein Capital Management held 38,980 shares of NeoGenomics worth $569K as of Q2 2026.
- Silverberg Bernstein Capital Management sold 1,700 NeoGenomics shares in Q2 2026, an estimated $16.4K.
- NeoGenomics made up 0.22% of Silverberg Bernstein Capital Management's portfolio in Q2 2026, its #45 holding.
- Silverberg Bernstein Capital Management first reported a position in NeoGenomics in Q4 2023 and has held it in 11 quarters since.
- 54 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on Silverberg Bernstein Capital Management's 13F filing for Q2 2026, filed 7 Jul 2026.